Hims & Hers Healths 109 Billion Trading Volume Plunges to 106th Rank as Shares Dip 021%

On September 22, 2025, Hims & Hers Health (HIMS) recorded a trading volume of $1.09 billion, marking a 48.48% decline from the previous day’s activity. The stock closed with a 0.21% decline, placing it at rank 106 among the most actively traded equities in the market.

Recent developments highlight strategic adjustments within the telehealth sector. Hims has been refining its digital healthcare offerings, with a focus on expanding virtual care platforms to address rising demand for remote medical services. Analysts suggest that the company’s pivot toward scalable, subscription-based models may influence investor sentiment in the coming quarters.

Operational updates indicate a shift in capital allocation priorities. Hims has redirected resources toward AI-driven diagnostics and partnerships with third-party providers to streamline service delivery. These moves aim to reduce per-patient costs while enhancing user retention rates, though market reactions remain cautious ahead of key performance metrics releases.

The back-testing framework for the volume-based strategy involves defining a U.S. equity universe, specifying entry/exit mechanics (e.g., pricing conventions, weighting schemes), and handling corporate actions. Daily volume data will be used to generate top-500 baskets, which will be rebalanced daily and tested from January 3, 2022, to the present. Key parameters include equal-weight allocation and exclusion of non-trading stocks on rebalancing dates.